Jj. Galligan et al., PHARMACOLOGICAL CHARACTERIZATION OF PURINOCEPTOR-MEDIATED CONSTRICTION OF SUBMUCOSAL ARTERIOLES IN GUINEA-PIG ILEUM, The Journal of pharmacology and experimental therapeutics, 274(3), 1995, pp. 1425-1430
Sympathetic nerve stimulation causes a constriction of submucosal arte
rioles that is mediated by ATP acting at P-2 receptors. In the present
study, we examined the P-2 receptor subtype mediating this response,
A computer-assisted video monitoring system measured drug-induced chan
ges in arteriolar diameter (resting diameter approximately 40-80 mu m)
in pieces of submucosa in vitro. The rank-order potency for vasoconst
riction caused by several ATP analogs was alpha,beta-methylene ATP (al
pha,beta-MeATP) > beta,gamma-methylene ATP = 2-methylthioATP > ATP > A
DP. Constrictions caused by alpha,beta-MeATP were competitively antago
nized by suramin (Kg = 3.2 mu M) and were noncompetitively blocked by
pyridoxalphosphate-6-azophenyl-2',4'-disulfonic acid (K-B = 0.5 mu M).
Norepinephrine-induced constrictions were not affected by suramin (10
0 mu M) or by pyridoxalphosphate-6-azophenyl-2',4'-disulfonic acid (3
mu M). Extracellular solutions with 0 added calcium prevented constric
tions caused by alpha,beta-MeATP (0.1-1.0 mu M), but not those caused
by norepinephrine (3 and 10 mu M). Nifedipine (0.3 and 1 mu M) reduced
constrictions caused by 40 and 60 mM extracellular potassium chloride
, but not those caused by alpha,beta MeATP. These data indicate that P
-2X receptors mediate constriction of submucosal arterioles. P-2X-medi
ated vasoconstriction is dependent on extracellular calcium, but calci
um entry through nifedipine-sensitive calcium channels does not contri
bute to P-2X-mediated vasoconstriction.